Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 45
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
VIRAFERONPEG 80MCG INJ PSO LQF 12X0,5ML+12J
0026001 EU/1/00/132/038 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 80MCG INJ PSO LQF 4X0,5ML+4J
0026999 EU/1/00/132/036 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 80MCG INJ PSO LQF 1X0,5ML+1J
0026998 EU/1/00/132/035 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 50MCG INJ PSO LQF 12X0,5ML+12J
0026997 EU/1/00/132/034 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 50MCG INJ PSO LQF 4X0,5ML+4J
0026995 EU/1/00/132/032 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 50MCG INJ PSO LQF 1X0,5ML+1J
0026994 EU/1/00/132/031 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 150MCG INJ PSO LQF 12+12X0,7ML AMP+12 SET
0026993 EU/1/00/132/030 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 120MCG INJ PSO LQF 12+12X0,7ML AMP+12 SET
0026992 EU/1/00/132/029 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 100MCG INJ PSO LQF 12+12X0,7ML AMP+12 SET
0026991 EU/1/00/132/028 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 80MCG INJ PSO LQF 12+12X0,7ML AMP+12 SET
0026990 EU/1/00/132/027 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 50MCG INJ PSO LQF 12+12X0,7ML AMP+12 SET
0026989 EU/1/00/132/026 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 150MCG INJ PSO LQF 6+6X0,7ML AMP
0026988 EU/1/00/132/025 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 150MCG INJ PSO LQF 4+4X0,7ML AMP+4 SET
0026987 EU/1/00/132/024 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 150MCG INJ PSO LQF 4+4X0,7ML AMP
0026986 EU/1/00/132/023 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 150MCG INJ PSO LQF 1+1X0,7ML AMP+SET
0026985 EU/1/00/132/022 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 150MCG INJ PSO LQF 1+1X0,7ML AMP
0026984 EU/1/00/132/021 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 120MCG INJ PSO LQF 6+6X0,7ML AMP
0026983 EU/1/00/132/020 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 120MCG INJ PSO LQF 4+4X0,7ML AMP+4 SET
0026982 EU/1/00/132/019 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 100MCG INJ PSO LQF 1X0,5ML+1J
0026002 EU/1/00/132/039 viraferonp.pdf viraferonp.pdf L03AB10 R
VIRAFERONPEG 100MCG INJ PSO LQF 4X0,5ML+4J
0026003 EU/1/00/132/040 viraferonp.pdf viraferonp.pdf L03AB10 R

1 2 3 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 19. January 2021 at 00:08
Last update of price and payment data: 1. January 2021 at 00:09